For example, high FDX1 expression in cancer stem cells decreased proliferation and overturned the epithelial–mesenchymal transition via tumor resistance to ammonified in human melanoma and promoted the treatment of resistant acute myeloid leukemia. This evidence concerns the gene FDX1 and melanoma.